Biocon to focus on insulin-based molecules
Biocon India Ltd is planning to focus a major part of its research on insulin-based molecules and will be launching its own branded recombinant human insulin formulation Insugen within two weeks. "We
Biocon India Ltd is planning to focus a major part of its research on insulin-based molecules and will be launching its own branded recombinant human insulin formulation Insugen within two weeks. "We